Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
QY-1-T by Zhongke Qiyuan (Shenzhen) Biotechnology for Hepatocellular Carcinoma: Likelihood of Approval
QY-1-T is under clinical development by Zhongke Qiyuan (Shenzhen) Biotechnology and currently in Phase II for Hepatocellular Carcinoma. According to...